PubRank

Friedrich Kommoss

Author PubWeight™ 22.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Borderline tumors of the ovary: clinical course and prognostic factors. Onkologie 2012 1.42
2 Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology. Gynecol Oncol 2011 1.38
3 Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 2008 1.29
4 The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas. J Pathol 2010 1.28
5 Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group. Eur J Cancer 2013 1.26
6 Uterine tumors resembling ovarian sex cord tumors (UTROSCT) lack the JAZF1-JJAZ1 translocation frequently seen in endometrial stromal tumors. Am J Surg Pathol 2009 1.12
7 Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int J Cancer 2012 1.10
8 NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res 2008 1.02
9 Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells. Int J Cancer 2011 0.94
10 p16 methylation does not affect protein expression in cervical carcinogenesis. Eur J Cancer 2008 0.92
11 Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers. Am J Surg Pathol 2015 0.91
12 Specialized pathology review in patients with ovarian cancer: results from a prospective study. Int J Gynecol Cancer 2013 0.91
13 A randomized trial comparing conventional cytology to liquid-based cytology and computer assistance. Int J Cancer 2012 0.88
14 Mature cystic teratoma of the ovary with struma and benign Brenner tumor: a case report with immunohistochemical characterization. Int J Gynecol Pathol 2002 0.83
15 Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol). Virchows Arch 2009 0.80
16 A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary. Histopathology 2013 0.80
17 Chemotherapy may be more effective in highly proliferative ovarian carcinomas--a translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol). Gynecol Oncol 2006 0.80
18 Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review. Histopathology 2013 0.80
19 Retracted The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter study. Gynecol Oncol 2004 0.80
20 No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group. Int J Gynecol Pathol 2008 0.79
21 The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary: A Subanalysis of the Prospective Multicenter ROBOT Study. Int J Gynecol Cancer 2015 0.77
22 Second Opinion Expert Pathology in Endometrial Cancer: Potential Clinical Implications. Int J Gynecol Cancer 2016 0.76
23 Ovarian Carcinoma Histotypes: Their Emergence as Important Prognostic and Predictive Markers. Oncology (Williston Park) 2016 0.75
24 Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany. Int J Gynecol Cancer 2009 0.75
25 FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors. Am J Surg Pathol 2015 0.75
26 Malignant transformation of a serous borderline tumor and early metastasis of associated low-grade serous carcinoma detected on screening mammography. J Clin Oncol 2011 0.75
27 [Hyperreactive luteomas during pregnancy--symptoms and complications: a case report]. Gynakol Geburtshilfliche Rundsch 2010 0.75
28 Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage. Int J Gynecol Pathol 2017 0.75